Twenty-five years of operation, over 1.8 million samples analysed and citations in more than 4,000 publications give this platform an unusually long track record. The Global Discovery Panel detects up to 5,400 metabolites across more than 70 biochemical pathways from a single biological sample, drawing on what Metabolon describes as the largest Level 1 annotated metabolite library available for commercial use. Where absolute quantification matters, roughly twenty targeted panels are on offer, among them amino acids, bile acids with their glycine and taurine conjugates, free fatty acids and short chain fatty acids, alongside lipidomics and a microbiome panel screening more than 800 small molecules. Groups that prefer to generate data in their own facility can run the Metabolon Verus Metabolomics Profiling Kit. BioPharma engagements are organised around biomarker discovery, target identification, pharmacokinetics and growth media analysis, with output delivered through an integrated bioinformatics platform that also handles multiomic integration.
Metabolon
Metabolon is the world's leading health technology company specializing in metabolomics, offering an advanced biochemistry platform that provides a comprehensive view of biological phenotypes. By mapping thousands of metabolic biomarkers, Metabolon helps pharmaceutical, biotech, and academic researchers uncover novel disease pathways, identify therapeutic targets, and accelerate biomarker discovery.
